OXYCODONE HYDROCHLORIDE, HYDROCODONE-
Opioid Use
St. Louis UniversitySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
23 Active assets in the Opioid Use cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
METHADONE Rutgers, The State University of New Jersey | Phase 4 | BBB |
HYDROMORPHON Endeavor Health | Phase 4 | BBB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Wake Forest University Health Sciences | Phase 4 | BBB |
FENTANYL University of Crete | Phase 4 | BB |
Bxcl501 Kaohsiung Veterans General Hospital. | Phase 4 | BB |
View all 28 →
Same molecule, other indications
OXYCODONE HYDROCHLORIDE, HYDROCODONE- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →